ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $16.41 and traded as low as $13.00. ZIVO Bioscience shares last traded at $13.00, with a volume of 630 shares traded.
ZIVO Bioscience Stock Performance
The firm has a market capitalization of $49.57 million, a P/E ratio of -2.66 and a beta of 0.02. The firm has a 50 day moving average price of $16.41 and a two-hundred day moving average price of $18.18.
ZIVO Bioscience Company Profile
(
Get Free Report)
ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ZIVO Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.
While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
